## GS: The Goldman Sachs Group, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.25 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: overbought RSI (72).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($906.43)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Form FWP GOLDMAN SACHS GROUP INC Filed by: GOLDMAN SACHS GROUP INC**
- Source: StreetInsider | 20260105T190822 | Neutral | Relevance: 100%
- Goldman Sachs Group Inc. has filed Form FWP for Market Linked Securities linked to NVIDIA, AMD, and Tesla common stocks, due January 12, 2029. These auto-callable securities offer leveraged upside participation, contingent absolute return, and contingent downside principal at risk. The filing includes a summary of terms, hypothetical payout profiles, and detailed risk factors associated with this complex investment.

**2. Goldman Sachs (GS) sees regulation driving next wave of institutional crypto adoption**
- Source: CoinDesk | 20260105T162600 | Somewhat-Bullish | Relevance: 100%
- Goldman Sachs predicts that regulatory clarity and expanded crypto use cases beyond trading will fuel significant institutional adoption of digital assets. The firm highlights upcoming U.S. market structure legislation, particularly in early 2026, as a key catalyst that could unlock substantial institutional capital for tokenization, DeFi, and broader crypto engagement. Despite current modest allocations, a significant number of institutional asset managers plan to increase their exposure to crypto in the next year.

**3. Goldman Sachs stock hits all-time high at $920.01 USD By Investing.com**
- Source: Investing.com Canada | 20260105T150812 | Bullish | Relevance: 100%
- Goldman Sachs Group Inc. (GS) stock has reached an all-time high of $920.01 USD, reflecting a 61.29% increase over the past year and outperforming many competitors in revenue growth and profit margins. According to InvestingPro analysis, the company appears undervalued and its return on equity consistently exceeds industry averages. This milestone comes amidst increased strategic activity, including financing for Kennedy Wilson, investment in the TXSE Group, and leading a funding round for Skims.

**4. Form 424B2 GOLDMAN SACHS GROUP INC**
- Source: StreetInsider | 20260105T150612 | Neutral | Relevance: 100%
- Goldman Sachs Group Inc. has filed Form 424B2 for Leveraged Callable S&P 500 Futures Excess Return Index-Linked Notes due 2031. These notes do not bear interest and may be redeemed by Goldman Sachs, otherwise maturing based on the performance of the S&P 500 Futures Excess Return Index. The estimated value of the notes at issuance is between $885 and $925 per $1,000 face amount, highlighting potential risks including credit risk and volatility of the underlying index.

**5. Barclays Raises Goldman Sachs (GS) Price Target to $1048, Mainta**
- Source: GuruFocus | 20260105T161921 | Bullish | Relevance: 96%
- Barclays has raised its price target for Goldman Sachs (GS) to $1048 from $850, a significant 23.29% increase, while maintaining an Overweight rating. This update, reflecting sustained confidence in Goldman Sachs' performance, signals a positive outlook for the stock's potential growth. Other analyst ratings have also shown recent price target increases and rating adjustments for the financial institution.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | Barclays | $1048 | $850 | +23% |
| 2025-12-17 | Keefe, Bruyette | $971 | $870 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | Barclays | main | Overweight |
| 2025-12-17 | Keefe, Bruyette | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 6 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (-1.5%)
- Blackrock Inc.: 7.7% (+0.1%)
- State Street Corpora: 6.4% (-1.5%)
- JPMORGAN CHASE & CO: 4.7% (+99.2%)
- Morgan Stanley: 2.6% (-7.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +4.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.25 suggests fair value with growth premium. Quality metrics strong (margin 29%). Balance sheet: $2.1B free cash flow. Analyst sentiment positive (2 raises, avg +17%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $287.1B |
| Beta | 1.32 |
| 52W Range | $439.38 - $961.66 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.25 |
| Forward P/E | 17.1 |
| Current P/E | 19.5 |
| YoY Growth | 14.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 1.5% to 6.2% (+4.7% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 91st percentile. MRS_5 at 4.8% confirms short-term momentum alignment. AM_20 at 6.4% shows strong absolute momentum above own 20MA. Outperforming sector by 3.8pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.74), confirming momentum. RSI overbought at 72, risk of mean reversion. OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.25% (CS: 92) | Strong |
| RSI_14 | 71.5 | Overbought |
| MACD Histogram | 0.74 | Bullish |
| vs SMA20 | 1.064x | Above |
| vs SMA50 | 1.137x | Above |
| vs SMA200 | 1.337x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $948.81
- **Stop Loss:** $906.43 (4.5% risk)
- **Target:** $1033.57 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 32
- **Position Value:** $30,361.92
- **Portfolio %:** 30.36%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-15 (Est: $11.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $11.09 | $12.25 | +10.5% |
| 2025Q2 | $9.66 | $10.91 | +12.9% |
| 2025Q1 | $12.26 | $14.12 | +15.2% |
| 2024Q4 | $8.35 | $11.95 | +43.1% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*